Skip to main content

MODELOS COMPUTACIONALES PERSONALIZADOS DE EPOC PARA LA FENOTIPIFICACION DE PACIENTES.

FIS2017-89535-C2-1-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Nasal sprayed particle deposition in a human nasal cavity under different inhalation conditions

  • Calmet, Hadrien|||0000-0001-5443-761X
  • Inthavong, Kiao
  • Eguzkitza, Beatriz|||0000-0002-3302-6667
  • Lehmkuhl Barba, Oriol|||0000-0002-2670-1871
  • Houzeaux, Guillaume|||0000-0002-2592-1426
Deposition of polydisperse particles representing nasal spray application in a human nasal cavity was performed under transient breathing profiles of sniffing, constant flow, and breath hold. The LES turbulence model was used to describe the fluid phase. Particles were introduced into the flow field with initial spray conditions, including spray cone angle, insertion angle, and initial velocity. Since nasal spray atomizer design determines the particle conditions, fifteen particle size distributions were used, each defined by a log-normal distribution with a different volume mean diameter (Dv50). Particle deposition in the anterior region was approximately 80% when Dv50 > 50μm, and this decreased to 45% as Dv50 decreased to 10μ m for constant and sniff breathing conditions. The decrease in anterior deposition was countered with increased deposition in the middle and posterior regions. The significance of increased deposition in the middle region for drug delivery shows there is potential for nasal delivered drugs to reach the highly vascularised mucosal walls in the main nasal passages. For multiple targeted deposition sites, an optimisation equation was introduced where deposition results of any two targeted sites could be combined and a weighting between 0 to 1 was applied to each targeted site, representing the relative importance of each deposition site., This work was financially supported by CompBiomed (Grant agreement ID: 675451) under European Commission (H2020) and by the Spanish Ministry of Economy and competitiveness (Project INSPIRE (FIS2017-89535-C2-1-R)., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Nasal sprayed particle deposition in a human nasal cavity under different inhalation conditions

  • Calmet, Hadrien
  • Inthavong, Kiao
  • Eguzkitza, Beatriz
  • Lehmkuhl Barba, Oriol
  • Houzeaux, Guillaume
Deposition of polydisperse particles representing nasal spray application in a human nasal cavity was performed under transient breathing profiles of sniffing, constant flow, and breath hold. The LES turbulence model was used to describe the fluid phase. Particles were introduced into the flow field with initial spray conditions, including spray cone angle, insertion angle, and initial velocity. Since nasal spray atomizer design determines the particle conditions, fifteen particle size distributions were used, each defined by a log-normal distribution with a different volume mean diameter (Dv50). Particle deposition in the anterior region was approximately 80% when Dv50 > 50μm, and this decreased to 45% as Dv50 decreased to 10μ m for constant and sniff breathing conditions. The decrease in anterior deposition was countered with increased deposition in the middle and posterior regions. The significance of increased deposition in the middle region for drug delivery shows there is potential for nasal delivered drugs to reach the highly vascularised mucosal walls in the main nasal passages. For multiple targeted deposition sites, an optimisation equation was introduced where deposition results of any two targeted sites could be combined and a weighting between 0 to 1 was applied to each targeted site, representing the relative importance of each deposition site., This work was financially supported by CompBiomed (Grant agreement ID: 675451) under European Commission (H2020) and by the Spanish Ministry of Economy and competitiveness (Project INSPIRE (FIS2017-89535-C2-1-R)., Peer Reviewed, Postprint (published version)